PUT - SPRINTER OPEN END - ELI LILLY & CO | Market Closed - Deutsche Boerse AG 02:01:29 2024-05-15 pm EDT | ||
| 16.86 EUR | -10.94% |
|
| Current month | +10.31% | ||
| 1 month | -3.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 16.86 | -10.94% |
| 24-05-14 | 18.93 | -1.51% |
| 24-05-13 | 19.22 | +3.39% |
| 24-05-10 | 18.59 | +5.51% |
| 24-05-09 | 17.62 | +1.50% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 02:01 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| WKN | VD0KJV |
| ISIN | DE000VD0KJV5 |
| Date issued | 2024-02-19 |
| Strike | 961.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 16.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.43 € |
|---|---|
| Lowest since issue | 15.26 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
764
USD
Average target price
850.4
USD
Spread / Average Target
+11.31%
- Stock Market
- Certificates
- Certificat
